Literature DB >> 6806388

The value of immunohistological screening in the production of monoclonal antibodies.

M Naiem, J Gerdes, Z Abdulaziz, C A Sunderland, M J Allington, H Stein, D Y Mason.   

Abstract

This paper describes an immunoperoxidase technique for labelling cryostat tissue sections which is routinely used in the authors' laboratories both in the initial screening of hybridoma culture supernatants, and also during the subsequent cloning and growth of antibody-secreting cell lines. The technique can readily be performed on 100 samples in less than 3 h and is free of non-specific background labelling. The staining pattern of a monoclonal antibody on a single tissue section allows semiquantitative assessment of its reactivity against a wide variety of tissue constituents and is thus inherently much more informative than conventional screening techniques (such as binding assays) which yield only a single numerical value for each test performed. In consequence it is often possible to identify the probable specificity of a new monoclonal antibody at the primary screening stage. A further important advantage of immunohistological screening is that it detects antigens on cells or other tissue structures which do not readily enter suspension and also antibodies against nuclear and cytoplasmic antigens. Examples of monoclonal antibodies analysed by immunohistological screening include antibodies against C3b receptor, HLA-DR, factor VIII-related antigen, human syncytiotrophoblast, dendritic reticulum cells and a proliferation-associated cell surface glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806388     DOI: 10.1016/0022-1759(82)90221-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.

Authors:  D V Parums; J L Cordell; K Micklem; A R Heryet; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

Review 2.  Practical suggestions for successful immunoenzyme double-staining experiments.

Authors:  C M van der Loos; A E Becker; J J van den Oord
Journal:  Histochem J       Date:  1993-01

3.  Monoclonal antibody to cytokeratin for use in routine histopathology.

Authors:  C A Makin; L G Bobrow; W F Bodmer
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  HLA-DR positive cells in the human placenta.

Authors:  L Sutton; D Y Mason; C W Redman
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

5.  Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80.

Authors:  M Miyasaka; I Heron; L Dudler; R N Cahill; L Forni; T Knaak; Z Trnka
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

6.  Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone.

Authors:  M E Brecher; W A Franklin; M A Simon
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

7.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours.

Authors:  I Kuzu; R Bicknell; A L Harris; M Jones; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

8.  A novel internal antigen which distinguishes germinal centre cells from other B-cell types.

Authors:  K Pulford; K J Micklem; M Jones; F Pezzella; K M Mayne; H Morrison; J Thomas; B Falini; A Norton; D Y Mason
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

9.  Osteosarcomas and Ewing's sarcomas. Comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants.

Authors:  T Löning; J Liebsch; G Delling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

Authors:  K Takahashi; J B Mulliken; H P Kozakewich; R A Rogers; J Folkman; R A Ezekowitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.